{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/MRNX/news?page=13"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":79.5,"timestamp":1788206400000,"preClose":76.89,"halted":0,"volume":478375,"hourTrading":{"tag":"盘后","latestPrice":77.79,"preClose":79.5,"latestTime":"19:56 EDT","volume":3679,"amount":286657.975,"timestamp":1788220586653,"change":-1.71,"changeRate":-0.021509,"amplitude":0.028805},"delay":0,"changeRate":0.033944596176355826,"floatShares":430000,"shares":430000,"eps":0,"marketStatus":"Not Yet Opened","change":2.61,"latestTime":"08-31 16:00:00 EDT","open":72.03,"high":83.5,"low":72.03,"amount":37903980.93625,"amplitude":0.149174,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":76.89,"sharesOutstanding":30000,"nav":76.81,"aum":33028300,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":72.45,"preClose":76.89,"latestTime":"09:28 EDT","volume":8296,"amount":599371.64792,"timestamp":1788182919364,"change":-4.44,"changeRate":-0.057745,"amplitude":0.04539},"postHourTrading":{"tag":"盘后","latestPrice":77.79,"preClose":79.5,"latestTime":"19:56 EDT","volume":3679,"amount":286657.975,"timestamp":1788220586653,"change":-1.71,"changeRate":-0.021509,"amplitude":0.028805},"volumeRatio":0.756768,"impliedVol":1.4013,"impliedVolPercentile":1},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":430000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.756768,"shares":430000,"dividePrice":0,"high":83.5,"amplitude":0.149174,"preClose":76.89,"low":72.03,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":79.5,"eps":0,"divideRate":0,"volume":478375,"delay":0,"ttmEps":0,"open":72.03,"prevYearClose":20.61,"prevWeekClose":76.89,"prevMonthClose":24.27,"prevQuarterClose":42.65,"fiveDayClose":79.95,"twentyDayClose":24.5876,"sixtyDayClose":24.6055},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:20,pageCount:13,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1184678054","title":"Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback","url":"https://stock-news.laohu8.com/highlight/detail?id=1184678054","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184678054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:15","pubTimestamp":1787127336,"startTime":"0","endTime":"0","summary":"Andy Acker, Portfolio Manager for healthcare and biotech strategies at Janus Henderson Investors, notes that despite interest rates remaining higher than markets anticipated at the start of the year,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC","MRNY","GTPE","IYG","IJT","SPCK","IBBJ","IBB","BIS","BK4585","PBE","BBP","BIB","MRNX","BK4588","QSML","IWO","IAI","BK4582","JDOC","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660413569","title":"Trump Picks White House Adviser Heidi Overton to Run FDA, Source Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660413569","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660413569?lang=en_us&edition=fundamental","pubTime":"2026-08-19 08:35","pubTimestamp":1787099724,"startTime":"0","endTime":"0","summary":"UPDATE 3-Trump picks White House adviser Heidi Overton to run FDA, source saysAug 18 (Reuters)-U.S. President Donald Trump has chosen White House policy aide Heidi Overton to lead the Food and Drug Ad","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL6N44G00Q:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","MRNX","BK4505","IE00BJJMRZ35.SGD","MRNY","SRPU","BK4585","BK4588","IE00BJT1NW94.SGD","IE0002141913.USD","BK4551","BK4548","REPL","IE0009355771.USD","BK4139","BK4534","MRNA","BK4568","BK4532","RGNX","SRPT","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","IDNA","LGHT","GNOM","BK4563","WDNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660595493","title":"Amylyx Phase 3 data support FDA approval, says Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2660595493","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660595493?lang=en_us&edition=fundamental","pubTime":"2026-08-18 22:05","pubTimestamp":1787061936,"startTime":"0","endTime":"0","summary":"Citi says Amylyx’s (AMLX) avexitide showed a “highly differentiated” profile in the Phase 3 LUCIDITY study, a 78 participant, placebo-controlled tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-phase-3-data-support-fda-approval-says-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","BK4007","FRTY","PINK","BK4588","BBP","IBB","TBXU","IDNA","AMLX","LFSC","TECB","SYNB","RSPH","IEIH","IYH","GNMX","BMED","NVIB","XLVX","LABU","MEDI","GDOC","PSCH","BK4585","MRNY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":13,"pageCount":13,"totalSize":243,"code":"91000000","status":"200"}]}}